MK-1496

MK-1496 is an orally active and highly selective PLK1 inhibitor. MK-1496 exerts antitumor effects by inducing G2/M phase arrest and apoptosis in tumor cells. MK-1496 can be used in research related to parotid gland carcinoma and small cell lung cancer.

Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.

  • CAS. Nr.: 1037254-47-9
  • Formel: C14H24N2O
  • Molecular Weight:236.35
  • Speicherung:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Biologische Aktivität
  • Chemical Information
  • Protokoll
  • Reinheit & Dokumentation
  • Verweise
  • Help & FAQs

Alle Polo-like Kinase (PLK) Isoform-spezifische Produkte anzeigen

More
MOQ
Minimum order quantity
100 mg

Angebot einholen Auf Lager

Other size
Angebot einholen
Please select quantity
Amount: USD 0.00